The objectives of the present study were twofold: (i) to characterize the location of CD44+ EOC stem cells in tissue samples and (ii) to determine whether the CD44+ EOC stem cell “load” correlates with clinical parameters in ovarian cancer patients. The gene discussed is CD44; the disease is ovarian cancer.